MeSH term
Frequency | Condition_Probility | Abnormalities, Multiple/*genetics | 5 | 1.0 |
*Chromosomes, Human, Pair 22 | 13 | 5.0 |
Female | 12 | 0.0 |
Humans | 19 | 0.0 |
In Situ Hybridization, Fluorescence | 9 | 0.0 |
Infant | 7 | 0.0 |
Karyotyping | 5 | 0.0 |
Syndrome | 8 | 0.0 |
*Translocation, Genetic | 3 | 0.0 |
Animals | 8 | 0.0 |
Embryonic and Fetal Development | 2 | 0.0 |
Male | 9 | 0.0 |
Mice | 6 | 0.0 |
Phenotype | 4 | 0.0 |
Pregnancy | 4 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 9 | 0.0 |
Base Sequence | 6 | 0.0 |
*Chromosome Deletion | 7 | 0.0 |
DiGeorge Syndrome/*genetics | 7 | 16.0 |
Research Support, Non-U.S. Gov't | 14 | 0.0 |
Adolescent | 5 | 0.0 |
Adult | 6 | 0.0 |
Child | 7 | 0.0 |
Child, Preschool | 5 | 0.0 |
Chromosome Mapping | 5 | 0.0 |
Face/*abnormalities | 3 | 7.0 |
Heart Defects, Congenital/*genetics | 4 | 10.0 |
*Cell Cycle Proteins | 2 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Heart Defects, Congenital/genetics | 4 | 11.0 |
DNA Probes | 2 | 0.0 |
Infant, Newborn | 2 | 0.0 |
Pedigree | 6 | 0.0 |
Chromosome Deletion | 4 | 0.0 |
Molecular Sequence Data | 5 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
*Chromosome Mapping | 3 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
DNA, Complementary | 2 | 0.0 |
DiGeorge Syndrome/genetics | 4 | 25.0 |
Learning Disorders/genetics | 2 | 25.0 |
Cell Line | 2 | 0.0 |
Translocation, Genetic | 3 | 0.0 |
Amino Acid Sequence | 2 | 0.0 |
Comparative Study | 3 | 0.0 |
